CoChat

Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study

Hamrahian, Amir H., Yuen, Kevin C. J., Gordon, Murray B., Pulaski-Liebert, Karen J., Bena, James, Biller, Beverly M. K. · 2016 · Pituitary

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Context Recent studies suggest using lower GH cut-points for the glucagon stimulation test (GST) in diagnosing adult GH deficiency (GHD), especially in obese patients. There are limited data on evaluating GH and hypothalamic-pituitary-adrenal (HPA) axes using weight-based dosing for the GST. Objective To define GH and cortisol cut-points to diagnose adult GHD and secondary adrenal insufficiency (SAI) using the GST, and to compare fixed-dose (FD: 1 or 1.5 mg in patients >90 kg) with weight-based dosing (WB: 0.03 mg/kg). Response to the insulin tolerance test (ITT) was considered the gold standard, using GH and cortisol cut-points of ≥3 ng/ml and ≥18 µg/dL, respectively. Design 28 Patients with hypothalamic-pituitary disease and 1-2 (n = 14) or ≥3 (n = 14) pituitary hormone deficiencies, and 14 control subjects matched for age, sex, estrogen status and body mass index (BMI) underwent the ITT, FD- and WB-GST in random order. Results Age, sex ratio and BMI were comparable between the three groups. The best GH cut-point for diagnosis of GHD was 1.0 (92 % sensitivity, 100 % specificity) and 2.0 ng/mL (96 % sensitivity and 100 % specificity) for FD- and WB-GST, respectively. Age negatively correlated with peak GH during FD-GST (r = -0.32, P = 0.04), but not WB-GST. The best cortisol cut-point for diagnosis of SAI was 8.8 µg/dL (92 % sensitivity, 100 % specificity) and 11.2 µg/dL (92 % sensitivity and 100 % specificity) for FD-GST and WB-GST, respectively. Nausea was the most common…

Overview

Integrity signals

Registry

Crossref · 10.1007/s11102-016-0712-7

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 35 references

Cited by

See all 97

Metadata

Authors
Hamrahian, A. H., Yuen, K. C. J., Gordon, M. B., Pulaski-Liebert, K. J., Bena, J., & Biller, B. M. K.
Affiliations
  • Cleveland Clinic (US)
  • Swedish Medical Center (US)
  • Allegheny General Hospital (US)
  • Cleveland Clinic Research (US)
  • Massachusetts General Hospital (US)
Corresponding author
Hamrahian, Amir H.
Venue
Pituitary
Published
2016-02-20
Volume
19
Issue
3
Pages
332-341
ISSN
  • 1386-341X (ISSN-L)
  • 1573-7403
OpenAlex
W2277973416
Cited by
92
References
35
Citations by year
2026: 4 · 2025: 5 · 2024: 14 · 2023: 6 · 2022: 10 · 2021: 7 · 2020: 11 · 2019: 9 · 2018: 9 · 2017: 11 · 2016: 5
FWCI
11.38
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Pituitary (publishedVersion)
  • PubMed (publishedVersion)
Funders
Novo Nordisk (IIS-000160)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
glucagon stimulation test, adult growth hormone deficiency, secondary adrenal insufficiency, weight-based dosing, insulin tolerance test, hypothalamic-pituitary-adrenal axis, pituitary hormone deficiency, obesity, sensitivity and specificity, seizure risk, pituitary adenoma, pituitary apoplexy
MeSH terms
Adenoma, Adrenal Insufficiency, Adult, Aged, Blood Glucose, Body Weight, Cosyntropin, Craniopharyngioma, Dose-Response Relationship, Drug, Female, Glucagon, Hormones, Humans, Hydrocortisone, Hypoglycemic Agents, Hypopituitarism, Hypothalamo-Hypophyseal System, Insulin, Male, Middle Aged, Pituitary Neoplasms, Pituitary-Adrenal System, Reference Values, Sensitivity and Specificity, Case-Control Studies, Human Growth Hormone, Central Nervous System Cysts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study. https://app.cochat.ai/papers/10.1007/s11102-016-0712-7
The paper
Hamrahian, A. H., Yuen, K. C. J., Gordon, M. B., Pulaski-Liebert, K. J., Bena, J., & Biller, B. M. K. (2016). Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study. Pituitary. https://doi.org/10.1007/s11102-016-0712-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.